Related Experiment Video
Updated: May 18, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Pharmacogenomics and individualized medicine: translating science into practice
K R Crews1, J K Hicks, C-H Pui
1Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, Tennessee, USA. kristine.crews@stjude.org
Clinical Pharmacology and Therapeutics
|September 6, 2012
Summary
Pharmacogenomics research aims to personalize medicine by understanding how genes affect drug responses. Translating these findings into clinical practice requires standardized results interpretation, clear guidelines, and decision support systems for better patient outcomes.
Area of Science:
- Pharmacogenomics
- Genetics
- Clinical Pharmacology
Background:
- Individual drug responses are influenced by genetic variations.
- Pharmacogenomics seeks to optimize patient therapy by leveraging genomic variability.
- Research spans from genotype-phenotype discovery to clinical impact trials.
Purpose of the Study:
- To explore the potential of pharmacogenomics in individualizing patient therapy.
- To identify key factors for the clinical implementation of pharmacogenomics.
- To address the slow translation of pharmacogenomics research into practice.
Main Methods:
- Review of translational research from genotype-phenotype discovery to clinical trials.
- Analysis of factors influencing the clinical application of pharmacogenomics.
- Identification of essential components for successful practice integration.
Main Results:
- Pharmacogenomics research has advanced the understanding of genetic influences on drug response.
- Significant potential exists for pharmacogenomics in individual patient care.
- The translation of research findings into clinical practice remains a challenge.
Conclusions:
- Successful clinical implementation of pharmacogenomics necessitates consistent interpretation of test results.
- Availability of clinical guidelines for genotype-guided prescribing is crucial.
- Knowledge-based decision support systems are vital for integrating pharmacogenomics into routine care.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...